View Item 

Show simple item record

Successful Treatment of Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Patients With Immunodeficiency With Extended Nirmatrelvir/Ritonavir: Case Series.
dc.contributor.authorBreeden, Madison
dc.contributor.authorAitken, Samuel L
dc.contributor.authorBaang, Ji Hoon
dc.contributor.authorGravelin, Misty
dc.contributor.authorKaul, Daniel R
dc.contributor.authorLauring, Adam S
dc.contributor.authorPetty, Lindsay A
dc.contributor.authorGregg, Kevin S
dc.coverage.spatialUnited States
dc.date.accessioned2023-06-01T16:11:21Z
dc.date.available2023-06-01T16:11:21Z
dc.date.issued2023-04
dc.identifier.issn2328-8957
dc.identifier.issn2328-8957
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pubmed/37089775
dc.identifier.urihttps://hdl.handle.net/2027.42/176791en
dc.description.abstractImmunocompromised patients with B-cell deficiencies are at risk for prolonged symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We describe 4 patients treated for B-cell malignancies with B-cell-depleting therapies who developed persistent SARS-CoV-2 infection and had resolution of symptoms following an extended course of nirmatrelvir/ritonavir.
dc.format.mediumElectronic-eCollection
dc.languageeng
dc.publisherOxford University Press (OUP)
dc.rightsLicence for published version: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectSARS-CoV-2
dc.subjectimmunodeficiency
dc.subjectprolonged infection
dc.titleSuccessful Treatment of Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Patients With Immunodeficiency With Extended Nirmatrelvir/Ritonavir: Case Series.
dc.typeArticle
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/176791/2/Successful Treatment of Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Patients With Immunodeficienc.pdf
dc.identifier.doi10.1093/ofid/ofad189
dc.identifier.doihttps://dx.doi.org/10.7302/7640
dc.identifier.doihttps://dx.doi.org/10.7302/7640
dc.identifier.sourceOpen Forum Infect Dis
dc.description.versionPublished online
dc.date.updated2023-06-01T16:11:19Z
dc.identifier.orcid0000-0003-2368-740X
dc.identifier.orcid0000-0002-5925-4289
dc.identifier.orcid0000-0003-2906-8335
dc.identifier.orcid0000-0002-8731-105X
dc.identifier.orcid0000-0003-3661-2490
dc.description.filedescriptionDescription of Successful Treatment of Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Patients With Immunodeficienc.pdf : Published version
dc.identifier.volume10
dc.identifier.issue4
dc.identifier.startpageofad189
dc.identifier.name-orcidBreeden, Madison; 0000-0003-2368-740X
dc.identifier.name-orcidAitken, Samuel L
dc.identifier.name-orcidBaang, Ji Hoon; 0000-0002-5925-4289
dc.identifier.name-orcidGravelin, Misty
dc.identifier.name-orcidKaul, Daniel R
dc.identifier.name-orcidLauring, Adam S; 0000-0003-2906-8335
dc.identifier.name-orcidPetty, Lindsay A; 0000-0002-8731-105X
dc.identifier.name-orcidGregg, Kevin S; 0000-0003-3661-2490
dc.working.doi10.7302/7640en
dc.owningcollnameInternal Medicine, Department of


Files in this item

Name:
Successful Treatment of Prolonged ...
Size:
206.0KB
Format:
PDF
Description:
Published version
View/Open

Show simple item record

Licence for published version: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Except where otherwise noted, this item's license is described as Licence for published version: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.